Myelodysplastic Syndrome

Patients with myelodysplastic syndrome who choose to undergo hematopoietic cell transplantation demo

Myelodysplastic Syndromes

Optimizing Outcomes in Low-Risk Myelodysplastic Syndromes

By

Lauren Burke

April 15, 2022

Diagnosis, goals of care, and treatment options for MDS are discussed in a presentation at 2022 ONA Summit.

Next post in Myelodysplastic Syndromes

Rates of recurrence and bleeding were similar between the 3 treatments assessed, but rivaroxaban demonstrated lower mortality rates.

TP53-Mutant Acute Myeloid Leukemia and Myelodysplastic Syndromes: Is Transplant Effective?